
Vripride PM 2mg/500mg/15mg Tablet
Marketer
Gopal Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Vripride PM 2mg/500mg/15mg Tablet
Combiflex DM 2mg/500mg/15mg tablets effectively manage blood glucose in adults with type 2 diabetes. This triple-action formulation, used alongside diet and exercise, enhances insulin efficiency, reducing elevated blood sugar. Dosage and frequency should strictly adhere to your physician's instructions; always take with food to prevent gastric discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose risks dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician. Kidney function will be assessed before commencing treatment. Limit alcohol consumption as it may exacerbate side effects.
Uses of Vripride PM 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Vripride PM 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vripride PM 2mg/500mg/15mg tablet should be administered with a meal.
Common Side effects of Vripride PM 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Vripride PM 2mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment schedule. Ingest the Vripride PM 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
How Vripride PM 2mg/500mg/15mg Tablet works:
Vripride PM tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood sugar management when monotherapy or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Vripride PM 2mg/500mg/15mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vripride PM 2mg/500mg/15mg Tablet during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Vripride PM 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with impaired kidney function should use Vripride PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is essential. The use of Vripride PM 2mg/500mg/15mg tablets is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Vripride PM 2mg/500mg/15mg tablets cautiously, potentially requiring dose modification. Consult a physician before use. The use of Vripride PM 2mg/500mg/15mg tablets is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Vripride PM 2mg/500mg/15mg Tablet :
Should you forget a dose of Vripride PM 2mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vripride PM 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
